Kratos Defense Q3 Earnings Outpace Estimates, Revenues Increase Y/Y

Kratos’ Q3 2026 adjusted EPS of $0.24 beat consensus by 14.3% and rose 71.4% year over year, while revenue increased 35.7% to $471.8 million but missed estimates by 0.4%. Bookings reached $1.04 billion, the book-to-bill ratio was 2.2, and backlog rose to $2.65 billion; management raised 2026 adjusted EBITDA guidance to $176-$180 million. The quarter also included a $4.9 million operating loss, versus $7.1 million of operating income a year earlier, and management cited continued federal funding restrictions as a constraint on early 2027 performance.

Analysis

The key question is not whether demand exists, but whether Kratos can turn it into durable operating leverage. The sharp divergence between Government Solutions growth and Unmanned Systems weakness argues against treating the headline growth rate as a single, repeatable run rate: the latter’s decline has a prior-year shipment comparison effect, but future growth still depends on new program awards and delivery cadence. Meanwhile, higher SG&A, R&D and amortization alongside an operating loss make EBITDA guidance a less reliable proxy for near-term earnings conversion. Backlog helps visibility, but the unfunded portion and federal funding delays expose timing risk; award headlines may not translate promptly into cash receipts.

Near term, the setup is positive for sentiment but likely sensitive to the market’s reaction to cash conversion and margin quality. Over 1–3 months, verify quarterly operating margin, funded-backlog conversion, and whether the 2027 ramp is supported by executable awards rather than pipeline. Over 6–18 months, successful scale-up could support a growth premium; persistent spending ahead of revenue or delayed appropriations could instead compress it. The reported cash increase should not be treated as evidence of self-funded growth until its source and working-capital drivers are reconciled.

The contrarian risk is that investors extrapolate the backlog and 2027 outlook while underweighting funding timing and weak current operating profitability. RTX and Northrop Grumman offer larger-cap defense exposure, but this release alone does not establish a valuation-based relative-value case.

Key Decisions for Investors

• Avoid chasing KTOS solely on the beat or backlog. Consider initiating a small long only after the post-earnings price reaction stabilizes, with a defined review at the next report; require improving operating profitability and cash conversion to add.
• Treat the 2027 outlook as a catalyst watch, not a base-case certainty. Track funded-backlog conversion, appropriations timing, and management’s quarterly revenue cadence; cut the thesis if guidance is reduced or operating cash use materially worsens versus plan.
• Before taking a relative-value position against RTX or Northrop Grumman, compare valuation, order conversion, and margin trajectories. This article supplies no basis to infer either is a short or that KTOS is cheap.